144 related articles for article (PubMed ID: 12962870)
1. New strategies of cyclosporine monitoring in heart transplantation: initial results.
Arizón del Prado JM; Aumente Rubio MD; Cárdenas Aranzana M; López Malo de Molina MD; Segura Saint-Gerons J; López Granados A; Rodríguez Esteban E; Ruiz Ortiz M; Romo Peñas E; Muñoz Carvajal I; González Rodríguez JR; Segura Saint-Gerons C; Vallés Belsué F; Concha Ruiz M
Transplant Proc; 2003 Aug; 35(5):1984-7. PubMed ID: 12962870
[TBL] [Abstract][Full Text] [Related]
2. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
5. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
Wang CH; Ko WJ; Chou NK; Wang SS
Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
[TBL] [Abstract][Full Text] [Related]
6. Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazole.
Zakliczynski M; Krynicka A; Szewczyk M; Wojarski J; Zembala M
Transplant Proc; 2003 Sep; 35(6):2333-4. PubMed ID: 14529932
[TBL] [Abstract][Full Text] [Related]
7. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
10. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
[TBL] [Abstract][Full Text] [Related]
11. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
International Neoral Renal Transplantation Study Group.
Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring.
Aumente Rubio MD; Arizón del Prado JM; López Malo de Molina MD; Cárdenas Aranzana M; Segura Saint-Gerons J; López Granados A; Rodriguez Esteban E; Mesa Rubio D; Romo Peñas E; Segura Saint-Gerons C
Transplant Proc; 2003 Aug; 35(5):1988-91. PubMed ID: 12962871
[TBL] [Abstract][Full Text] [Related]
14. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
Iversen M; Nilsson F; Sipponen J; Eiskjaer H; Mared L; Bergan S; Nyström U; Fagertun HE; Solbu D; Simonsen S
J Heart Lung Transplant; 2009 Sep; 28(9):919-26. PubMed ID: 19716045
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
[TBL] [Abstract][Full Text] [Related]
18. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
John U; Ullrich S; Roskos M; Misselwitz J
Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
Wang CH; Ko WJ; Chou NK; Wang SS
Transplant Proc; 2004 Oct; 36(8):2386-7. PubMed ID: 15561257
[TBL] [Abstract][Full Text] [Related]
20. Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.
Wacke R; Rohde B; Engel G; Kundt G; Hehl EM; Bast R; Seiter H; Drewelow B
Eur J Clin Pharmacol; 2000 Apr; 56(1):43-8. PubMed ID: 10853876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
